Christopher Joseph McCabe : Citation Profile


Are you Christopher Joseph McCabe?

University of Leeds (15% share)
University of Alberta (15% share)

7

H index

6

i10 index

255

Citations

RESEARCH PRODUCTION:

15

Articles

4

Papers

RESEARCH ACTIVITY:

   10 years (2003 - 2013). See details.
   Cites by year: 25
   Journals where Christopher Joseph McCabe has often published
   Relations with other researchers
   Recent citing documents: 21.    Total self citations: 7 (2.67 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pmc184
   Updated: 2021-10-16    RAS profile: 2014-01-13    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Christopher Joseph McCabe.

Is cited by:

Claxton, Karl (17)

Brazier, John (14)

Tsuchiya, Aki (10)

Sculpher, Mark (9)

Culyer, Anthony (7)

Gerdtham, Ulf-G. (6)

Devlin, Nancy (6)

Brouwer, Werner (6)

Soares, Marta (5)

Rowen, Donna (5)

Walker, Simon (4)

Cites to:

Brazier, John (15)

Roberts, Jennifer (11)

Claxton, Karl (9)

Feeny, David (8)

Sculpher, Mark (6)

Zhang, Yuhao (3)

Gravelle, Hugh (2)

Rice, Nigel (2)

Ruud, Paul (2)

Culyer, Anthony (2)

Hausman, Jerry (2)

Main data


Where Christopher Joseph McCabe has published?


Journals with more than one article published# docs
Health Economics8
PharmacoEconomics3
Journal of Health Economics2

Working Papers Series with more than one paper published# docs
MPRA Paper / University Library of Munich, Germany3

Recent works citing Christopher Joseph McCabe (2021 and 2020)


YearTitle of citing document
2020Modelling the impact of physical activity on public health: A review and critique. (2020). Meads, David ; Candio, Paolo ; Bojke, Laura ; Hill, Andrew J. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:10:p:1155-1164.

Full description at Econpapers || Download paper

2021Eliciting SF-6Dv2 health state utilities using an anchored best-worst scaling technique. (2021). Chen, Gang ; Wu, Jing. In: Social Science & Medicine. RePEc:eee:socmed:v:279:y:2021:i:c:s0277953621003506.

Full description at Econpapers || Download paper

2020Challenges and Solutions for Integrating and Financing Personalized Medicine in Healthcare Systems: A Systematic Literature Review. (2020). Wagner, Joel ; Kalouguina, Veronika. In: Journal of Risk and Financial Management. RePEc:gam:jjrfmx:v:13:y:2020:i:11:p:283-:d:445735.

Full description at Econpapers || Download paper

2021Prince: An improved method for measuring incentivized preferences. (2021). Wakker, Peter P ; Dolder, Dennie ; Li, Zhihua ; Bleichrodt, Han ; Baillon, Aurelien ; Johnson, Cathleen. In: Journal of Risk and Uncertainty. RePEc:kap:jrisku:v:62:y:2021:i:1:d:10.1007_s11166-021-09346-9.

Full description at Econpapers || Download paper

2020A two-step procedure to generate utilities for the Infant health-related Quality of life Instrument (IQI). (2020). , Paul ; Vermeulen, Karin M ; Dainelli, Livia ; Detzel, Patrick ; Jabrayilov, Ruslan. In: PLOS ONE. RePEc:plo:pone00:0230852.

Full description at Econpapers || Download paper

2020Value judgment of new medical treatments: Societal and patient perspectives to inform priority setting in The Netherlands. (2020). , Paul ; Vermeulen, Karin M ; Nicolet, Anna. In: PLOS ONE. RePEc:plo:pone00:0235666.

Full description at Econpapers || Download paper

2021A model-based cost-utility analysis of multi-professional simulation training in obstetric emergencies. (2021). Pizzo, Elena ; Draycott, Tim ; Morris, Steve ; Lenguerrand, Erik ; Hung, Christopher Wai. In: PLOS ONE. RePEc:plo:pone00:0249031.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2021Systematic Review and Critique of Methods for Economic Evaluation of Digital Mental Health Interventions. (2021). Melton, Hollie ; Churchill, Rachel ; Goncalves, Pedro Saramago ; Marshall, David ; Bojke, Laura ; Jankovic, Dina ; Gega, Lina ; Brabyn, Sally. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:1:d:10.1007_s40258-020-00607-3.

Full description at Econpapers || Download paper

2020Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries. (2020). Santos, Rita ; Prat, A ; Henry, N ; Espin, J ; Mestre-Ferrandiz, J ; Borras, J M ; Jones, E ; Drummond, M ; Corbacho, B. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:4:d:10.1007_s10198-020-01160-5.

Full description at Econpapers || Download paper

2020Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale. (2020). Wright, Penny ; Kind, Paul ; Meads, David ; Odwyer, John. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:5:d:10.1007_s10198-020-01173-0.

Full description at Econpapers || Download paper

2020Discrete choice experiments to generate utility values for multi-attribute utility instruments: a systematic review of methods. (2020). Bahrampour, Mina ; Downes, Martin ; Scuffham, Paul A ; Norman, Richard ; Byrnes, Joshua. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01189-6.

Full description at Econpapers || Download paper

2020Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. (2020). Shatrov, Kosta ; Rabbe, Stefan ; Mollenkamp, Meilin ; Groot, Saskia ; Federici, Carlo ; Dams, Florian ; Ciani, Oriana ; Grigore, Bogdan ; Taylor, Rod S ; Zemplenyi, Antal. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00935-1.

Full description at Econpapers || Download paper

2020One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit. (2020). Hall, Peter ; Sutton, Andrew ; Awotwe, Isaac ; Paulden, Mike ; McCabe, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00869-3.

Full description at Econpapers || Download paper

2020After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6.

Full description at Econpapers || Download paper

2020Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?. (2020). Devlin, Nancy ; Rowen, Donna ; Ratcliffe, Julie ; Rivero-Arias, Oliver. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00873-7.

Full description at Econpapers || Download paper

2020Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling. (2020). Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard ; Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9.

Full description at Econpapers || Download paper

2021Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier. (2021). Paulden, Mike ; Hall, Peter ; Sutton, Andrew ; Tramonti, Giovanni ; McCabe, Christopher. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00983-7.

Full description at Econpapers || Download paper

2021EQ-5D-Y Value Set for Slovenia. (2021). Ogorevc, Marko ; Rupel, Valentina Prevolnik. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-020-00994-4.

Full description at Econpapers || Download paper

2020Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review. (2020). Armina, T I ; Hovels, Anke M ; Klungel, Olaf ; Frederix, Gerardus W ; Saragih, Sarah Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-019-0162-z.

Full description at Econpapers || Download paper

Works by Christopher Joseph McCabe:


YearTitleTypeCited
2005A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence In: Working Papers.
[Full Text][Citation analysis]
paper7
2012Estimating the population utility function: A parametric Bayesian approach In: European Journal of Operational Research.
[Full Text][Citation analysis]
article1
2006Using rank data to estimate health state utility models In: Journal of Health Economics.
[Full Text][Citation analysis]
article28
2007Multi-attribute utility function or statistical inference models: A comparison of health state valuation models using the HUI2 health state classification system In: Journal of Health Economics.
[Full Text][Citation analysis]
article5
2008The NICE Cost-Effectiveness Threshold: What it is and What that Means In: MPRA Paper.
[Full Text][Citation analysis]
paper70
2003Health state values for the HUI 2 descriptive system: results from a UK survey In: MPRA Paper.
[Full Text][Citation analysis]
paper15
2005Health state values for the HUI 2 descriptive system: results from a UK survey.(2005) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 15
article
2004Estimating population cardinal health state valuation models from individual ordinal (rank) health state preference data In: MPRA Paper.
[Full Text][Citation analysis]
paper1
2013Measuring health outcomes of adolescents: report from a pilot study In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2013What Evidence Is There for the Reimbursement of Personalised Medicine? In: PharmacoEconomics.
[Full Text][Citation analysis]
article3
2013Constructing Indirect Utility Models: Some Observations on the Principles and Practice of Mapping to Obtain Health State Utilities In: PharmacoEconomics.
[Full Text][Citation analysis]
article2
2013Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help? In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2005Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra In: Health Economics.
[Full Text][Citation analysis]
article61
2006Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion In: Health Economics.
[Full Text][Citation analysis]
article16
2006Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey In: Health Economics.
[Full Text][Citation analysis]
article1
2006Whither trial‐based economic evaluation for health care decision making? In: Health Economics.
[Full Text][Citation analysis]
article37
2006Erratum to ‘Health state values for the health utilities index mark 2 descriptive system: results from a UK valuation survey’ Health Economics 2005; 14(3): 231–244 In: Health Economics.
[Full Text][Citation analysis]
article1
2007‘Is there a case for using visual analogue scale valuations in CUA’ by Parkin and Devlin a response: ‘yes there is a case, but what does it add to ordinal data?’ In: Health Economics.
[Full Text][Citation analysis]
article4
2007Response to Shmueli In: Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 2 2021. Contact: CitEc Team